Physician profile
Thomas Wesley Mitchell
NPI 1639631666
$4,585.29
in general payments reported to CMS, 2019-2025
14 companies · $415 in 2025
The $415 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,170 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,278 · Travel and Lodging: $1,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,278.20 |
| Travel and Lodging | $1,307.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,841.56 | 2024 | Gamma, Mako, Variax |
| Axogen | $660.92 | 2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Trimed, INC. | $248.79 | 2024-2025 | |
| Globus Medical, INC. | $235.96 | 2024 | Distal Radius II, Ankle Fracture System, Mini Fragment System |
| Medartis INC. | $163.31 | 2024-2025 | Aptus |
| Invictus Surgical Incorporated | $118.66 | 2025 | |
| Endo USA, INC. | $116.61 | 2024 | Xiaflex |
| Skeletal Dynamics INC | $44.61 | 2025 | Geminus, Ijs, Implate |
| Vericel Corporation | $36.07 | 2024 | Maci |
| Medinc of Texas | $28.86 | 2024 | |
| Depuy Synthes Sales INC. | $28.56 | 2024 | Na |
| Microport Orthopedics INC | $24.54 | 2024 | Mpo Hip System |
| Avanos Medical | $18.50 | 2025 | On-Q Pump and Accessories |
| Acera Surgical, INC. | $18.34 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.